WASHINGTON — Facing intense scrutiny from senators over his potential profit from vaccine lawsuits while serving as the ...

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that ...

Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...

With a volume of 4,802,873, the price of MRK is down -0.11% at $98.84. RSI indicators hint that the underlying stock is currently neutral between overbought and oversold. Next earnings are expected to ...

Kennedy Jr. earned more than $2.4 million as a consultant referring cases to the law firm Wisner Baum, government records show. Wisner Baum is suing Merck & Co. over allegations that the ...

We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we are going to take a look at where Merck & Co., Inc.

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

Can you pitch in a few bucks to help fund Mother Jones' investigative journalism? We're a nonprofit (so it's tax-deductible), ...

After UnitedHealthcare CEO Brian Thompson was shot to death in December, law enforcement records show a burst of police ...

Robert F. Kennedy Jr. is not qualified to be health and human services secretary for many reasons, chief among them being his ...

Robert F. Kennedy Jr. has built his fortune and reputation on disparaging the government scientists and institutions he's now ...

The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.